Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA-cascade-polymer, a new blood-pool agent: Preliminary experience

Investigative Radiology

Volumn 31, Issue 5, 1996, Pages 267-274

  Adam, Gerhard ^a   Mühler, Andreas ^b   Spüntrup, Elmar ^a   Neuerburg, Joerg M ^a   Kilbinger, Markus ^a   Bauer, Hans ^b   Fücezi, Laszlo ^a   Küpper, Werner ^a   Günther, Rolf W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

blood pool contrast agent; Breast neoplasms; experimental study; magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE CASCADE POLYMER; GADOLINIUM PENTETATE DERIVATIVE; GADOLINIUM PENTETATE MEGLUMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; BREAST TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL DETECTION;

EID: 0029969549     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199605000-00004     Document Type: Article

References (14)

1. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10: 199-204.
2. Harms SE, Flamig DP. MR imaging of the breast. J Magn Reson Imag 1993;3:277-283.
3. Kaiser WA, Zeitler E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Radiology 1989;170: 681-686.
4. Heywang SH, Wolf A, Pruss E, Hilbertz Th, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPa: Use and limitations. Radiology 1989;171:95-103.
5. Fischer U, v Heyden D, Vosshenrich R, Vieweg I, Grabbe E. Signalverhalten maligner und benigner Läsionen in der dynamischen 2D-MRT der Mamma. Fortschr Röntgenstr 1993;158: 287-292.
6. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: A potential new NMR contrast agent. AJR Am J Roentgenol 1984;142:619-624.
7. Wikström MG, Moseley ME, White DL, et al. Contrast enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989;24:609-615.
8. Adam G, Neuerburg J, Spüntrup E, Mühler A, Günther RW. 24-gadolinium-cascade-polymer: A potential blood-pool contrast agent for MR imaging. J Magn Reson Imag 1994;4:462-466.
9. Adam G, Neuerburg J, Spüntrup E, Mühler A, Scherer K, Günther RW. Dynamic contrast enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994;32:622-628.
10. Brasch RC, Shames DM, Cohen FM, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinoma. Invest Radiol 1994;29:S8-S11.
11. Moulton JE. Mammary tumors of the dog. In: Moulton JE ed. Tumors in domestic animals. 3rd ed. Berkley, Los Angeles, London: University of California Press, 1990:518-552.
12. Frese K. Vergleichende Pathologie der Mammatumoren bei Haustieren. Verh Dtsch Ges Path 1985;69:152-170.
13. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987;6:559-593.
14. Frouge Ch, Guinebretiere J-M, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049.